Overview

A Study of LY3437943 in Participants Who Have Obesity or Are Overweight

Status:
Recruiting
Trial end date:
2022-10-26
Target enrollment:
Participant gender:
Summary
This is a study of LY3437943 in participants who have obesity or are overweight. The main purpose is to learn more about how LY3437943 affects body weight loss. The study will last about 18 months and may include up to 18 visits.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company